Con: Methylene blue should not be used routinely for vasoplegia perioperatively

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 4, 2011, Pages 739-743

  Andritsos, Michael J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

cardiac surgery; methylene blue; vasoplegia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; METHYLENE BLUE; NORADRENALIN; PLACEBO; PROTAMINE;

ABDOMINAL PAIN; ABSCESS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; COMPETITIVE INHIBITION; CONFUSION; CONTINUOUS INFUSION; CORONARY HEMODYNAMICS; DIAPHORESIS; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG METABOLISM; FEVER; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART RIGHT ATRIUM PRESSURE; HEMOLYTIC ANEMIA; HUMAN; INCIDENCE; METHEMOGLOBINEMIA; MORBIDITY; MORTALITY; NAUSEA; NONHUMAN; PERIOPERATIVE PERIOD; PRECORDIAL PAIN; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPTIC SHOCK; SIDE EFFECT; SINGLE DRUG DOSE; SKIN DISCOLORATION; SKIN NECROSIS; SYSTEMIC VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOPLEGIA; VOMITING;

EID: 80052769792     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2011.04.007     Document Type: Note

References (69)

1. M. Friedrich, A. Brauer, and T. Tirilomis Methylene blue administration in severe systemic inflammatory response syndrome (SIRS) after thoracic surgery Ann Thorac Cardiovasc Surg 8 2002 306 310
2. G. Shanmugam Vasoplegic syndromeThe role of methylene blue Eur J Cardiothorac Surg 28 2005 705 710 (Pubitemid 41539325)
3. D.W. Landry, and J.A. Oliver The pathogenesis of vasodilatory shock N Engl J Med 345 2001 588 595
4. G.W. Fischer, and M.A. Levin Vasoplegia during cardiac surgery: Current concepts and management Semin Thorac Cardiovasc Surg 22 2010 140 144
5. J. Cremer, M. Martin, and H. Redl Systemic inflammatory response syndrome after cardiac operations Ann Thorac Surg 61 1996 1714 1720 (Pubitemid 26179719)
6. M.A. Levin, H.M. Lin, and J.G. Castillo Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome Circulation 120 2009 1664 1671
7. R.L. Levin, M.A. Degrange, and G.F. Bruno Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery Ann Thorac Surg 77 2004 496 499 (Pubitemid 38186498)
8. K.M. Taylor SIRSThe systemic inflammatory response syndrome after cardiac operations Ann Thorac Surg 61 1996 1607 1608 (Pubitemid 26179703)
9. M. Argenziano, J.M. Chen, and A.F. Choudhri Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 116 1998 973 980 (Pubitemid 28553541)
10. A. Donati, G. Conti, and S. Loggi Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med 30 2002 2271 2277 (Pubitemid 35191578)
11. E.S. Kwok, and D. Howes Use of methylene blue in sepsis: A systematic review J Intensive Care Med 21 2006 359 363 (Pubitemid 44664170)
12. G. Brown, D. Frankl, and T. Phang Continuous infusion of methylene blue for septic shock Postgrad Med J 72 1996 612 614 (Pubitemid 26345364)
13. S.F. Kemp, and R.F. Lockey Anaphylaxis: A review of causes and mechanisms J Allergy Clin Immunol 110 2002 341 348
14. A.I. Neugut, A.T. Ghatak, and R.L. Miller Anaphylaxis in the United States: An investigation into its epidemiology Arch Intern Med 161 2001 15 21 (Pubitemid 32052139)
15. K. Takakura, M. Mizogami, and S. Fukuda Protamine sulfate causes endothelium-independent vasorelaxation via inducible nitric oxide synthase pathway Can J Anaesth 53 2006 162 167
16. F. Viaro, M.B. Dalio, and P.R. Evora Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: Should methylene blue be the treatment of choice? Chest 122 2002 1061 1066
17. S.P. Stawicki, C. Sims, and B. Sarani Methylene blue and vasoplegia: Who, when, and how? Mini Rev Med Chem 8 2008 472 490
18. R.G. Leyh, T. Kofidis, and M. Struber Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg 125 2003 1426 1431 (Pubitemid 36759245)
19. A. Mekontso-Dessap, R. Houel, and C. Soustelle Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function Ann Thorac Surg 71 2001 1428 1432
20. P.R. Evora, P.J. Ribeiro, and J.C. de Andrade Methylene blue administration in SIRS after cardiac operations Ann Thorac Surg 63 1997 1212 1213 (Pubitemid 27191712)
21. W.J. Gomes, A.C. Carvalho, and J.H. Palma Vasoplegic syndrome after open heart surgery J Cardiovasc Surg (Torino) 39 1998 619 623 (Pubitemid 28526021)
22. R. Busse, and A. Mulsch Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells FEBS Lett 275 1990 87 90 (Pubitemid 20386182)
23. R.G. Kilbourn, S.S. Gross, and A. Jubran NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide Proc Natl Acad Sci U S A 87 1990 3629 3632
24. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: Physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
25. D.D. Rees, S. Cellek, and R.M. Palmer Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock Biochem Biophys Res Commun 173 1990 541 547
26. R. Schulz, E. Nava, and S. Moncada Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium Br J Pharmacol 105 1992 575 580
27. D. Beasley, and M. McGuiggin Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway J Exp Med 179 1994 71 80 (Pubitemid 24012972)
28. P.S. Myles, C.K. Leong, and J. Currey Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass J Cardiothorac Vasc Anesth 11 1997 571 574 (Pubitemid 27332934)
29. H.H. Schmidt NO, CO and OH Endogenous soluble guanylyl cyclase-activating factors FEBS Lett 307 1992 102 107
30. B. Mayer, F. Brunner, and K. Schmidt Inhibition of nitric oxide synthesis by methylene blue Biochem Pharmacol 45 1993 367 374 (Pubitemid 23042635)
31. B. Mayer, F. Brunner, and K. Schmidt Novel actions of methylene blue Eur Heart J 14 suppl I 1993 22 26 (Pubitemid 23362589)
32. R.M. Palmer The discovery of nitric oxide in the vessel wall A unifying concept in the pathogenesis of sepsis Arch Surg 128 1993 396 401 (Pubitemid 23115379)
33. P.R. Evora, C.H. Roselino, and P.M. Schiaveto Methylene blue in anaphylactic shock Ann Emerg Med 30 1997 240
34. A.M. Oliveira Neto, N.M. Duarte, and W.V. Vicente Methylene blue: An effective treatment for contrast medium-induced anaphylaxis Med Sci Monit 9 2003 CS102 CS106
35. K. Allegaert, M. Miserez, and T. Lerut Methemoglobinemia and hemolysis after enteral administration of methylene blue in a preterm infant: relevance for pediatric surgeons J Pediatr Surg 39 2004 E35 E37
36. S.M. Bradberry Occupational methaemoglobinaemia Mechanisms of production, features, diagnosis and management including the use of methylene blue Toxicol Rev 22 2003 13 27 (Pubitemid 37270709)
37. J. Clifton 2nd, and J.B. Leikin Methylene blue Am J Ther 10 2003 289 291
38. P.R. Evora, P.J. Ribeiro, and W.V. Vicente Methylene blue for vasoplegic syndrome treatment in heart surgery: Fifteen years of questions, answers, doubts and certainties Rev Bras Cir Cardiovasc 24 2009 279 288
39. C. Peter, D. Hongwan, and A. Kupfer Pharmacokinetics and organ distribution of intravenous and oral methylene blue Eur J Clin Pharmacol 56 2000 247 250 (Pubitemid 30456685)
40. E. Ozal, E. Kuralay, and V. Yildirim Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery Ann Thorac Surg 79 2005 1615 1619 (Pubitemid 40614576)
41. M. Grayling, and C.D. Deakin Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis J Thorac Cardiovasc Surg 125 2003 426 427 (Pubitemid 36228329)
42. P.R. Evora Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? J Thorac Cardiovasc Surg 119 2000 632 634 (Pubitemid 30146550)
43. A.D. Maslow, G. Stearns, and P. Butala The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass Anesth Analg 103 2006 2 8 (Pubitemid 44036021)
44. M. Albert, M.S. Lessin, and B.F. Gilchrist Methylene blue: Dangerous dye for neonates J Pediatr Surg 38 2003 1244 1245 (Pubitemid 37048052)
45. J.M. Rodrigues, A. Pazin Filho, and A.J. Rodrigues Methylene blue for clinical anaphylaxis treatment: A case report Sao Paulo Med J 125 2007 60 62 (Pubitemid 46813350)
46. J.C.S. Andrade, M.L. Batista Filho, and P.R.B. Evora Methylene blue administration in the treatment of the vasoplegic syndrome after cardiac surgery Rev Bras Cir Cardiovasc 11 1996 107 114
47. E.G. Leite, A. Ronald, and A.J. Rodrigues Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery? Interact Cardiovasc Thorac Surg 5 2006 774 778 (Pubitemid 44901245)
48. D. Lavigne Vasopressin and methylene blue: Alternate therapies in vasodilatory shock Semin Cardiothorac Vasc Anesth 14 2010 186 189
49. H.B. Ulusoy, H. Gul, and M. Seyrek The concentration-dependent contractile effect of methylene blue in the human internal mammary artery: A quantitative approach to its use in the vasoplegic syndrome J Cardiothoracic Vasc Anesth 22 2008 560 564
50. J.A. Almeida, S.M. Riordan, and J. Liu Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome Eur J Gastroenterol Hepatol 19 2007 341 346 (Pubitemid 46412078)
51. M. Andresen, A. Dougnac, and O. Diaz Use of methylene blue in patients with refractory septic shock: Impact on hemodynamics and gas exchange J Crit Care 13 1998 164 168 (Pubitemid 29015271)
52. G. Sweet, and S.B. Standiford Methylene-blue-associated encephalopathy J Am Coll Surg 204 2007 454 458 (Pubitemid 46283509)
53. H. Zhang, P. Rogiers, and J.C. Preiser Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock Crit Care Med 23 1995 1711 1721
54. A. Petros, G. Lamb, and A. Leone Effects of a nitric oxide synthase inhibitor in humans with septic shock Cardiovasc Res 28 1994 34 39
55. E.V. Suborov, V.V. Kuzkov, and M. Sobhkhez The effects of methylene blue on ovine post-pneumonectomy pulmonary oedema Acta Anaesthesiol Scand 54 2010 1089 1096
56. Y.P. Liao, D.Z. Hung, and D.Y. Yang Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia Vet Hum Toxicol 44 2002 19 21
57. M.R. Sills, and W.H. Zinkham Methylene blue-induced Heinz body hemolytic anemia Arch Pediatr Adolesc Med 148 1994 306 310 (Pubitemid 24083980)
58. C.M. McRobb, and D.W. Holt Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review J Extra Corpor Technol 40 2008 206 214
59. B.D. Goldstein Exacerbation of dapsone-induced Heinz body hemolytic anemia following treatment with methylene blue Am J Med Sci 267 1974 291 297
60. W.F. Schleifer, J.W. Chapin, and D.J. Cuka Methylene blue and pulse oximeter readings in a patient undergoing transurethral procedure Urology 36 1990 537 538
61. A.J. Mittnacht Prolonged decrease of regional cerebral saturation readings with the INVOS device after continuous intravenous methylene blue administration Anesth Analg 106 2008 1327 (Pubitemid 351450569)
62. R. Porat, S. Gilbert, and D. Magilner Methylene blue-induced phototoxicity: An unrecognized complication Pediatrics 97 1996 717 721 (Pubitemid 26138105)
63. P. Dewachter, C. Mouton-Faivre, and P. Trechot Severe anaphylactic shock with methylene blue instillation Anesth Analg 101 2005 149 150 (Pubitemid 40853366)
64. B.K. Ng, and A.J. Cameron The role of methylene blue in serotonin syndrome: A systematic review Psychosomatics 51 2010 194 200
65. L. Vutskits, A. Briner, and P. Klauser Adverse effects of methylene blue on the central nervous system Anesthesiology 108 2008 684 692 (Pubitemid 351440590)
66. P.K. Gillman Methylene blue is a potent monoamine oxidase inhibitor Can J Anaesth 55 2008 311 312 (Pubitemid 351668941)
67. R.R. Ramsay, C. Dunford, and P.K. Gillman Methylene blue and serotonin toxicity: Inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction Br J Pharmacol 152 2007 946 951 (Pubitemid 350100489)
68. P.K. Gillman Methylene blue and serotonin toxicity: Definite causal link Psychosomatics 51 2010 448 449
69. P.K. Gillman CNS toxicity involving methylene blue: The exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity J Psychopharmacol 25 2010 429 436